Shots:
- Shockwave Medical (J&J MedTech’s company) has initiated the pivotal FORWARD CAD IDE trial with first pts enrolled, evaluating safety & efficacy of the Shockwave Javelin coronary IVL catheter to treat calcified, hard-to-cross de novo coronary artery lesions prior to stenting
- Trial will evaluate the coronary IVL catheter in ~158 pts with mod. to sev. calcified, stenotic de novo coronary lesions, presenting with stable angina or post-ACS stabilization, & eligible for non-emergent PCI at 35 sites in the US & UK
- Shockwave Javelin includes a single distal emitter that produces ultrasonic shockwaves, with each shockwave creating spherical energy field to allow lithotripsy closer to calcium than balloon-based platforms
Ref: J&J | Image: J&J MedTech
Related News:- J&J MedTech Reports the US FDA‘s 510(k) Clearance of MONARCH QUEST for Robot-Assisted Bronchoscopy
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
